medigraphic.com
ISSN 1729-519X (Print)

2021, Number 1

<< Back Next >>

Revista Habanera de Ciencias Médicas 2021; 20 (1)

Seroprevalence of infection with Trypanosoma cruzi and associated factors in a population of Cumaral, Meta, Colombia

Sánchez-Lerma L, Pavas-Escobar N, Pérez-Gutiérrez N, González-Robayo M, Campo-Palacio S

Language: Spanish
References: 22
Page: 1-11
PDF size: 874.27 Kb.


ABSTRACT

Introduction: Chagas disease is a parasitic zoonosis caused byTrypanosoma cruzi, a vector-born protozoan that is transmitted to humans. Field studies predict that one-third of around 18 millionT cruzi-infected humans will die of Chagas disease in Latin America.
Objective: To determine the seroprevalence of the infection with Trypanosoma cruzi and to identify some risk factors associated with this condition in Cumaral, Meta, Colombia.
Material and Methods: A descriptive, cross-sectional study was conducted. Blood samples were collected from subjects that had been living in urban and rural areas of Cumaral municipality for more than six months. An ELISA-IgG method with total extracts (first test) was used for the detection of Trypanosoma cruzy IgG. A recombinant-based ELISA was performed as a confirmatory test. Doubtful results were sent to the National Institute for Health for confirmation by indirect immunofluorescence assay. Prism 8 for MacOS (version 8.2.1) was used for statistical analysis.
Results: In the screening for Chagas disease, 2,7 % of all the cases tested were positive. When comparing subjects with positive and negative results, differences between age, scholarship and materials used in the construction of house walls were evidenced.
Conclusions: The results provide useful information about housing conditions and seroprevalence of the disease that help to evaluate the effectiveness of the arrangement that provides and strengthens the access to the diagnosis and treatment of the disease.


REFERENCES

  1. Palmezano J, Plazas L, Rivera K, Rueda V. Enfermedad de Chagas: Realidad de una patología frecuente en Santander, Colombia. Médicas UIS. 2015; 28(1):81-90.

  2. Reyes M, Torres A, Esteban L, Flórez M, Angulo V. Riesgo de transmisión de la Enfermedad de Chagas por intrusión de triatominos y mamíferos silvestres en Bucaramanga, Santander, Colombia. Biomédica. 2017; 37:68-78.

  3. Cermeño J, Askew E, Salazar F. Seroprevalencia de la Enfermedad de Chagas en comunidades indígenas de los estados Bolívar y Delta Amacuro, Venezuela. Biomedicina. 2013; 25: 373-81.

  4. Monroy A, Pedraza A, Prada C. Prevalencia de anticuerpos anti Trypanosoma cruzi en mujeres en edad fértil. Biomédica. 2016; 36:90-6.

  5. Fica A, Salinas M, Jercic M, Dabanch J, Soto A, Quintanilla S, et al. Enfermedad de Chagas del sistema nervioso central en un paciente con SIDA demostrada por métodos cuantitativos moleculares. Rev Chilena Infectol. 2017; 34:69-76.

  6. Organización Panamericana de la Salud. Enfermedad de Chagas en las comunidades indígenas de la Sierra Nevada de Santa Marta. Bogotá: Cisnecolor; 2011.

  7. Instituto Nacional de Salud. Gestión para la vigilancia entomológica y control de la transmisión de la Enfermedad de Chagas [Internet]. Bogotá: Instituto Nacional de Salud; 2010 [Citado 18/06/2019]. Disponible en: https://www.minsalud.gov.co/Documents/Salud%20P%C3%BAblica/Ola%20invernal/Entomologica%20Chagas.pdf

  8. Tzizik D, Borchardt R. Chagas disease. An underrecognized diagnosis. JAAPA [Internet]. 2018 [Citado 11/10/2019];31:30-3. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/30489388

  9. World Health Organization. Chagas disease in Latin America: an epidemiological update based on 2010 estimates. Wkly Epidemiol Rec [Internet]. 2015 [Citado 18/06/2019];90:33-44. Disponible en: https://apps.who.int/iris/bitstream/handle/10665/242316/WER9006_33-44.PDF?sequence=1&isAllowed=y

  10. González S, Paredes V, Edward B, Crescencio J, Guerra Á, Rivas N, et al. Seroprevalence and geographical distribution of sero-positive blood donors to Trypanosoma cruzi at the central blood bank of the National Medical Center "La Raza." Transfusion [Internet]. 2019 [Citado 18/06/2019];59:639-47. Disponible en: https://onlinelibrary.wiley.com/doi/abs/10.1111/trf.15074

  11. Cecere M, Rodríguez L, Vázquez G, Kitron U, Gürtler R. Community-based surveillance and control of chagas disease vectors in remote rural areas of the Argentine Chaco: A five-year follow-up. Acta Trop [Internet]. 2019 [Citado11/10/2019];191:108-15. Disponible en: https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_0001706X_v191_n_p108_Cecere

  12. Paim D, Ribeiro G , Cardoso F, Neves F, Barbosa R, Bittencourt D, et al. Seroprevalence of Trypanosoma cruzi infection among blood donors in the state of Bahia, Brazil. Rev Soc Bras Med Trop [Internet]. 2019 [Citado11/10/2019 ];52:1-7. Disponible en: http://www.scielo.br/scielo.php?pid=S0037-86822019000100327&script=sci_arttext&tlng=en

  13. León C, Ortiz M, Tovar C, Negrete J, Arroyo E, González C, et al. Detection of Trypanosoma cruzi strains circulating in Córdoba department (Colombia) isolated from triatomines (Hemiptera: Reduviidae) collected by the community. Biomédica. 2019 ;39 (2):265-77.

  14. Díaz N, De Carvalho B , Nitz N, Hagström L, Vital T, Hecht M. Congenital Chagas disease: alert of research negligence. Rev Soc Bras Med Trop [Internet]. 2019 [Citado 11/10/2019];52:1-6. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/30810649

  15. Danesi E, Codebó M, Sosa S. Congenital transmission of Trypanosoma cruzi. Argentina 2002-2014. Medicina (Buenos Aires) [Internet]. 2019 [Citado11/10/2019],79:81-9. Disponible en: http://www.medicinabuenosaires.com/PMID/31048272.pdf

  16. Salm A, Gertsch J. Cultural perception of triatomine bugs and Chagas disease in Bolivia: a cross-sectional field study. Parasit Vectors [Internet]. 2019 [Citado12/10/2019];12:291. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558697/

  17. Báez J, Olivero J, Salazar L, Suazo I. Effects of atmospheric oscillations on infectious diseases: the case of Chagas disease in Chile. Mem Inst Oswaldo Cruz. 2019; 114:e180569.

  18. Espinosa J, Sánchez A, Salvador F, Sao A, Sulleiro E, Molina I. A retrospective study on the influence of siblings' relatedness in Bolivian patients with chronic Chagas disease. Parasit Vectors [Internet]. 2019 [Citado 13/10/2019];12(1):260. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533702/

  19. Stanaway JD, Roth G. The burden of Chagas disease. Estimates and challenges Glob Heart [Internet]. 2015 [Citado 19/06/2019];10(3):139-44. Disponible en: https://www.sciencedirect.com/science/article/pii/S221181601500174X?via%3Dihub

  20. Alonso J, Cortés N, Pinazo M, Bottazzi M, Abril M, Barreira F, et al. Strategies to enhance access to diagnosis and treatment for Chagas disease patients in Latin America. Expert Rev Anti Infect Ther [Internet]. 2019 [Citado 19/10/2019];17(3):145-57. Disponible en: https://www.tandfonline.com/doi/full/10.1080/14787210.2019.1577731

  21. Mendicino D, Colussi C, Stafuza M, Manattini S, Montemaggiore S, Nepote M. Seroprevalencia de Chagas en mayores de 14 años de áreas rurales del Chaco Santafesino. Rev Fac Cien Med Univ Nac Córdoba [Internet]. 2019 [Citado19/10/2019];76:47-51. Disponible en: https://revistas.unc.edu.ar/index.php/med/article/view/21946/23326

  22. Fernández M , Gaspe M, Gürtler R. Inequalities in the social determinants of health and Chagas disease transmission risk in indigenous and creole households in the Argentine Chaco. Parasit Vectors [Internet]. 2019 [Citado 19/10/2019];12:184. Disponible en: https://parasitesandvectors.biomedcentral.com/articles/10.1186/s13071-019-3444-5




2020     |     www.medigraphic.com